SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg1/27/2006 4:00:16 AM
   of 1139
 
The management group has had itself rewarded for a work well(????) done during 2005. Ok, let's say: for some work done.

       
Name stock grant value options

Blum 7,000 $174,230 50,000
Clark 55,000 $1,368,950 155,000
Goodkin 8,000 $199,120 55,000
Kliewer 5,000 $124,450 35,000
St. John 4,500 $112,005 30,000
Stein 10,000 $248,900 70,000
Stocks 4,500 $112,005 30,000
Wilcox 7,000 $174,230 50,000
Yetman 4500 $112,005 30,000
Total $2,625,000 505,000



When options are not enough (and their future value in doubt) top them up with some shares, seems to be the rule at Icos. Really, these guys shouldn't have anything until they produce something positive for the shareholders.

Clark of course leads the league and number two in the awards race is Stein!! The finance guy. What's going on over there?

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext